Skip to content

Tele-Electrocardiography in Emergency Cardiac Care

Tele-electrocardiography in Emergency Cardiac Care

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00075088
Enrollment
794
Registered
2004-01-05
Start date
2003-09-30
Completion date
2009-06-30
Last updated
2015-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain, Myocardial Infarction

Keywords

Telemedicine, Emergency Care, Cardiac

Brief summary

The purpose of this study is to see whether individuals who access the 911 emergency medical system with a heart attack or severe chest pain will receive more timely hospital treatment and better outcomes if hospital clinicians are provided with earlier and more complete electrocardiography (ECG) information.

Detailed description

This is a Phase III study. Patients will be randomized (like tossing a coin) to 1 of 2 groups: Group 1: Patients will have pre-hospital ECG intervention. Group 2: Patients will have routine emergency heart care. Information will be collected about time symptoms started, clinical management, and other measures. All patients will be contacted by telephone 12 months later and interviewed as to whether they experienced any cardiac symptoms.

Interventions

DEVICEElectrocardiogram (ECG) Intervention

Pre-hospital electrocardiographic (ECG) monitoring with special software to detect myocardial ischemia and to automatically transmit an ECG to the destination hospital emergency department with a voice alarm announcing Incoming ECG from the field and print out in the ED.

ECG in the ED as part of routine clinical practice.

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All individuals in Santa Cruz County in California who call 911 with symptoms of acute coronary syndrome (chest pain, shortness of breath, anginal equivalent).

Exclusion criteria

* Those who don't meet the above inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Hospital Time to Treatment for Patients With Unstable Angina/Non-STEMIDay 1Time from ED arrival to first drug was determined as recommended by American College of Cardiology/American Heart Association 2007 guidelines for management of patients with unstable angina/non-STEMI
Hospital Time to Treatment for Patients With ST-elevation Myocardial Infarction (STEMI)Day 1Mean door-to-balloon time

Secondary

MeasureTime frame
Rehospitalization and Mortality4 years

Countries

United States

Participant flow

Recruitment details

For 5-years, paramedics responding to 911 calls for symptoms suggestive of Acute Coronary Syndrome (ACS) in one U.S. county transmitted an electrocardiogram (ECG) to the target emergency department (ED) for all patients meeting eligibility criteria. A central computer received the transmission and randomized to an experimental or control group.

Pre-assignment details

4,219 calls to 911 for ACS symptoms were made over the study period; 3,103 pre-hospital ECGs were transmitted by paramedics; 2,353 ECGs were successfully received by the target emergency department (ED); 794 patients consented. If patient consent was not obtained, data were not used.

Participants by arm

ArmCount
Electrocardiogram (ECG) Intervention
Patients randomized to the experimental group had their ECGs printed out in the target ED with an audible voice alarm. Print-out of the pre-hospital ECG in the target ED was the intervention.
403
Routine Clinical Practice
Control patients had an ECG conducted after hospital arrival, as was the standard of care in the county.
391
Total794

Baseline characteristics

CharacteristicElectrocardiogram (ECG) InterventionRoutine Clinical PracticeTotal
Age, Continuous70 years
STANDARD_DEVIATION 15
71 years
STANDARD_DEVIATION 14
70 years
STANDARD_DEVIATION 14
Region of Enrollment
United States
403 participants391 participants794 participants
Sex: Female, Male
Female
189 Participants193 Participants382 Participants
Sex: Female, Male
Male
214 Participants198 Participants412 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
5 / 4033 / 39140 / 40

Outcome results

Primary

Hospital Time to Treatment for Patients With ST-elevation Myocardial Infarction (STEMI)

Mean door-to-balloon time

Time frame: Day 1

Population: 42 patients with STEMI who received primary percutaneous coronary intervention

ArmMeasureValue (MEAN)Dispersion
Electrocardiogram (ECG) InterventionHospital Time to Treatment for Patients With ST-elevation Myocardial Infarction (STEMI)78 minutesStandard Deviation 22
Routine Clinical PracticeHospital Time to Treatment for Patients With ST-elevation Myocardial Infarction (STEMI)101 minutesStandard Deviation 56
Primary

Hospital Time to Treatment for Patients With Unstable Angina/Non-STEMI

Time from ED arrival to first drug was determined as recommended by American College of Cardiology/American Heart Association 2007 guidelines for management of patients with unstable angina/non-STEMI

Time frame: Day 1

Population: Patients with unstable angina/non-STEMI. Four patients with Do Not Resuscitate (DNR) orders were excluded from this time-to-treatment analysis

ArmMeasureValue (MEAN)Dispersion
Electrocardiogram (ECG) InterventionHospital Time to Treatment for Patients With Unstable Angina/Non-STEMI23 minutesStandard Deviation 12
Routine Clinical PracticeHospital Time to Treatment for Patients With Unstable Angina/Non-STEMI31 minutesStandard Deviation 16
Secondary

Rehospitalization and Mortality

Time frame: 4 years

Population: we did not have the resources to achieve this secondary aim that required long-term follow up (a labor intensive job). The PI is now retired.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026